Exterran Corporation (EXTN)

US30227H1068 - Common Stock

4.58  -0.26 (-5.37%)

After market: 4.66 +0.08 (+1.75%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EXTN. EXTN was compared to 65 industry peers in the Energy Equipment & Services industry. EXTN may be in some trouble as it scores bad on both profitability and health. EXTN is valued expensive and it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EXTN has reported negative net income.
In the past year EXTN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: EXTN reported negative net income in multiple years.
Of the past 5 years EXTN 4 years had a positive operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA -6.56%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.45%
PM (TTM) -11.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

EXTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EXTN has more shares outstanding
The debt/assets ratio for EXTN is higher compared to a year ago.

2.2 Solvency

EXTN has an Altman-Z score of 0.13. This is a bad value and indicates that EXTN is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 4.65 is on the high side and indicates that EXTN has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 4.65
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC8.73%

2.3 Liquidity

EXTN has a Current Ratio of 1.29. This is a normal value and indicates that EXTN is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.05 indicates that EXTN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.05

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.62% over the past year.
The Revenue has grown by 26.06% in the past year. This is a very strong growth!
Measured over the past years, EXTN shows a decrease in Revenue. The Revenue has been decreasing by -6.99% on average per year.
EPS 1Y (TTM)20.62%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q74.7%
Revenue 1Y (TTM)26.06%
Revenue growth 3Y-22.63%
Revenue growth 5Y-6.99%
Revenue growth Q2Q51.35%

3.2 Future

The Earnings Per Share is expected to grow by 0.59% on average over the next years.
The Revenue is expected to grow by 7.28% on average over the next years.
EPS Next Y-6.04%
EPS Next 2Y11.47%
EPS Next 3Y3.16%
EPS Next 5Y0.59%
Revenue Next Year42.26%
Revenue Next 2Y24.76%
Revenue Next 3Y12.67%
Revenue Next 5Y7.28%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EXTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EXTN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.81

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.47%
EPS Next 3Y3.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EXTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Exterran Corporation

NYSE:EXTN (10/12/2022, 7:14:15 PM)

After market: 4.66 +0.08 (+1.75%)

4.58

-0.26 (-5.37%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap153.41M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -0.45%
PM (TTM) -11.16%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 4.65
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.29
Quick Ratio 1.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)20.62%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-6.04%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.06%
Revenue growth 3Y-22.63%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y